Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

Tectoridins Modulate Skeletal and Cardiac Muscle Sarcoplasmic Reticulum Calcium-Release Channels

Keshore R. Bidasee, Anderson Maxwell, William F. Reynolds, Vimalkumar Patel and Henry R. Besch Jr.
Journal of Pharmacology and Experimental Therapeutics June 2000, 293 (3) 1074-1083;
Keshore R. Bidasee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anderson Maxwell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William F. Reynolds
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vimalkumar Patel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry R. Besch Jr.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The isoflavones tectoridin (TTR) and 3′-hydroxy TTR (3′-TTR) were isolated from an Ayurvedic herbal preparation Vacä and evaluated for their affinity and effect on ryanodine receptors (RyR) using junctional sarcoplasmic reticulum vesicles (JSRVs). In [3H]ryanodine displacement binding affinity assays, TTR and 3′-TTR exhibited IC50 values of 17.3 ± 1.3 μM (Kd = 6.7 ± 0.4 μM) and 6.6 ± 1.4 μM (Kd = 2.4 ± 0.2 μM), respectively, for fast skeletal muscle RyR (RyR1) compared with an IC50 value for ryanodine of 6.2 ± 0.4 nM (Kd = 2.4 nM). TTR demonstrated a 3-fold higher affinity for cardiac RyR (RyR2) [IC50 value of 5.2 ± 0.6 μM (Kd = 0.95 ± 0.3 μM)] than for RyR1. The displacement isotherms for both TTRs paralleled that for ryanodine, consistent with the notion that all three are likely binding to similar site(s) on the receptors. Calcium efflux from and calcium influx into JSRVs were used to measure function effects of TTRs on binding to RyR. In calcium efflux assays, TTR (up to 1 mM) enhanced the release of 45Ca2+ from JSRVs in a concentration-dependent manner (EC50act of 750 μM). Higher concentrations deactivated (partially closed) RyR1. 3′-TTR had similar effects, but was approximately 2-fold more potent, exhibiting an EC50act value of 480 μM. Using passive calcium influx assays, TTR activated and deactivated RyR1 in a time- and concentration-dependent manner. The aglycone tectorigenin also was effective in displacing [3H]ryanodine from RyR1 but not from RyR2. These results demonstrate that TTRs are capable of interacting at ryanodine binding sites to differentially modulate fast skeletal and cardiac calcium-release channels.

Footnotes

  • Send reprint requests to: Keshore R. Bidasee, Ph.D., Department of Pharmacology and Toxicology, 635 Barnhill Dr., MS A417, Indianapolis, IN 46202-5120. E-mail: kbidase{at}iupui.edu

  • ↵1 This work was supported in part by a grant from the Biomedical Research Committee of the Indiana University School of Medicine (to K.R.B.) and by the Ralph W. and Grace M. Showalter Trust (to H.R.B.).

  • 2 A preliminary report of this study was presented at the 40th Annual Meeting of the Biophysical Society, Baltimore, MD, February 17–21, 1996, and published in abstract form [(1996)Biophys J70:A281].

  • Abbreviations:
    SR
    sarcoplasmic reticulum
    RyR
    ryanodine receptors
    TTR
    tectoridin
    3′-TTR
    3′-hydroxy TTR
    RyR1
    skeletal muscle ryanodine receptor
    RyR2
    cardiac muscle ryanodine receptor
    JSRV
    junctional sarcoplasmic reticulum vesicles
    TLC
    thin-layer chromatography
    CV
    crude sarcoplasmic reticular membrane vesicles
    PMSF
    phenylmethyl sulfonyl fluoride
    JSRV
    junctional SR membrane vesicles
    E1c
    CHCl3 extract
    • Received December 28, 1999.
    • Accepted February 29, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 293 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 293, Issue 3
1 Jun 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tectoridins Modulate Skeletal and Cardiac Muscle Sarcoplasmic Reticulum Calcium-Release Channels
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCELLULAR AND MOLECULAR

Tectoridins Modulate Skeletal and Cardiac Muscle Sarcoplasmic Reticulum Calcium-Release Channels

Keshore R. Bidasee, Anderson Maxwell, William F. Reynolds, Vimalkumar Patel and Henry R. Besch
Journal of Pharmacology and Experimental Therapeutics June 1, 2000, 293 (3) 1074-1083;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleCELLULAR AND MOLECULAR

Tectoridins Modulate Skeletal and Cardiac Muscle Sarcoplasmic Reticulum Calcium-Release Channels

Keshore R. Bidasee, Anderson Maxwell, William F. Reynolds, Vimalkumar Patel and Henry R. Besch
Journal of Pharmacology and Experimental Therapeutics June 1, 2000, 293 (3) 1074-1083;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Chlorogenic Acid Inhibits Breast Cancer Metastasis
  • SNAP25 and mGluRs Control Pathological Tau Release
  • N-Stearoylethanolamine Inhibits Platelet Reactivity
Show more Cellular and Molecular

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics